Retinoic acid induces a specific membrane glycoprotein in human epithelial cell lines.
Retinoic acid (RA) inhibits growth, increases the cytokeratin content, and alters the cytoskeleton of the human cervical cell line NHIK 3025. Using RA-treated NHIK 3025 cells as immunogen we prepared murine monoclonal antibodies (IgG1) which recognized an RA-induced cell-surface antigen which could not be detected in untreated NHIK 3025 cells. Analysis of the Triton soluble proteins by SDS-gel electrophoresis and immunoblotting revealed that the cell-surface antigen is a 140-kDa glycoprotein (gp140). gp140 was also shown to be induced by RA in HeLa S3 cells and constitutively expressed in the human trophoblast cell line BeWo. gp140 was also detected in other human epithelial cell lines, but not in human hematopoietic cells. Expression of gp140 was induced in HeLa S3 cells by nanomolar concentrations of RA, and in NHIK 3025 cells by micromolar amounts (1-10 microM). The glycoprotein was detectable 3-6 h following exposure to RA and its expression was reversible upon removal of RA from the medium. Our results indicate that gp140 is a newly identified RA-inducible epithelial membrane glycoprotein which may represent a phenotypic differentiation marker for epithelial cells.
Bakke
O
O
Biotechnology Group, SINTEF, Trondheim, Norway.
Espevik
T
T
D000818:Animals; D000911:Antibodies, Monoclonal; D002460:Cell Line; D004591:Electrophoresis, Polyacrylamide Gel; D006367:HeLa Cells; D006801:Humans; D015151:Immunoblotting; D007700:Kinetics; D008562:Membrane Glycoproteins / Q000096:biosynthesis* / Q000276:immunology; D008970:Molecular Weight; D009439:Neuraminidase / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology*; D014357:Trypsin / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014801:Vitamin A / Q000494:pharmacology
D000911:Antibodies, Monoclonal; D008562:Membrane Glycoproteins; D014801:Vitamin A; D014212:Tretinoin; D009439:Neuraminidase; D014357:Trypsin